https://ijpcr.net/ijpcr <p><strong><em>International Journal of Pharmacology and Clinical Research (IJPCR) </em></strong>is a peer-reviewed, quarterly official international journal allowing access to abstracts<strong>&nbsp;</strong>and<strong>&nbsp;</strong>full-text. The journal is devoted to the promotion of pharmaceutical sciences and related disciplines (Pharmacology, Biopharmaceutics, Pharmacokinetics, Pharmaceutical Medicinal Chemistry, Computational Chemistry &amp; Molecular Drug Design, Pharmacognosy &amp; Phytochemistry, Pharmaceutical Analysis, Pharmacy Practice, Clinical &amp; Hospital Pharmacy, Cell Biology, Genomics &amp; Proteomics, Pharmacogenomics, Bioinformatics including biotechnology, cell &amp; molecular biology, Pharmaceutical biotechnology/microbiology, medical and other life sciences).</p> <p><strong>ISSN</strong>&nbsp;-&nbsp;<strong><em>International Journal of Pharmacology and Clinical Research (IJPCR)</em></strong></p> <p><strong>Online</strong>:<strong>&nbsp;</strong>2521-2206</p> <p><strong><em>International Journal of Pharmacology and Clinical Research </em></strong>seeks to foster multidisciplinary research and collaboration among scientists, pharmaceutical industries and healthcare sector as well as provide an international forum for the communication and evaluation of data, methods and opinions in pharmaceutical sciences and related disciplines. Although primarily devoted to original research papers, the journal particularly welcomes reviews on current topics of special interest and relevance. All manuscripts will be subjected to rapid peer review. Those of high quality (not previously published and not already under consideration for publication) will be published.</p> Futuristic Publications en-US International Journal of Pharmacology and Clinical Research (IJPCR) 2521-2206 https://ijpcr.net/ijpcr/article/view/629 <p>Neuropharmacology studies the effects of drugs on the nervous system's cellular function and how neurons communicate. The focus is on developing drugs to treat neurological disorders like pain, neurodegenerative diseases, psychological disorders, and addiction. Understanding human behaviour and thought processes is crucial for neuropharmacology to advance medicine. This article discusses behavioural and molecular neuropharmacology, specifically the direct receptors, ion channels, and neurotransmitters that drug actions manipulate. The blood-brain barrier is a significant obstacle to drug delivery, but advances in nanotechnology are creating novel approaches to improve drug delivery for neurological disorders. Nanoscale drug delivery systems like exosomes, liposomes, polymeric nanoparticles, and aptamer-conjugated nanoparticles have shown to increase brain penetration, improve drug efficacy, and decrease systemic toxicity. However, challenges such as scalability, regulatory challenges, and immunogenicity remain.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p> Nampelly Raaziiv Varma Tajuddin Shaik Copyright (c) 2025-07-01 2025-07-01 9 3 241 247 10.61096/ijpcr.v9.iss3.2025.241-247